Evidence map›Paper›PMID 27458810›Full record

ArticlePloS one2016

Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades.

Lucas Matheus Stangherlin, Fabiane Lucy Ferreira Castro, Raphael Salles Scortegagna Medeiros, Juliana Mariotti Guerra, Lidia Midori Kimura, Neuza Kazumi Shirata, Suely Nonogaki, Claudia Januário Dos Santos, Maria Cristina Carlan Silva

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, andClinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lucas Matheus StangherlinLaboratório de Biologia Molecular de Patógenos, Virologia Molecular, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, São Paulo, Brazil.
Fabiane Lucy Ferreira CastroLaboratório de Biologia Molecular de Patógenos, Virologia Molecular, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, São Paulo, Brazil.
Raphael Salles Scortegagna MedeirosDepartamento de Anatomia Patológica do Hospital das Clínicas da Faculdade Medicina da Universidade de São Paulo, São Paulo, Brazil.
Juliana Mariotti GuerraNúcleo de Patologia Quantitativa (NPQ) do Centro de Patologia do Instituto Adolfo Lutz (IAL), São Paulo, Brazil.
Lidia Midori KimuraNúcleo de Patologia Quantitativa (NPQ) do Centro de Patologia do Instituto Adolfo Lutz (IAL), São Paulo, Brazil.
Neuza Kazumi ShirataNúcleo de Patologia Quantitativa (NPQ) do Centro de Patologia do Instituto Adolfo Lutz (IAL), São Paulo, Brazil.
Suely NonogakiNúcleo de Patologia Quantitativa (NPQ) do Centro de Patologia do Instituto Adolfo Lutz (IAL), São Paulo, Brazil.
Claudia Januário Dos SantosLaboratório de Biologia Molecular de Patógenos, Virologia Molecular, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, São Paulo, Brazil.
Maria Cristina Carlan SilvaLaboratório de Biologia Molecular de Patógenos, Virologia Molecular, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, São Paulo, Brazil.
Instituto Adolfo Lutz · BRUniversidade Federal do ABC · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliomas are the most common type of primary brain tumors. The most aggressive type, Glioblastoma multiforme (GBM), is one of the deadliest human diseases, with an average survival at diagnosis of about 1 year. Previous evidence suggests a link between human cytomegalovirus (HCMV) and gliomas. HCMV has been shown to be present in these tumors and several viral proteins can have oncogenic properties in glioma cells. Here we have investigated the presence of HCMV DNA, RNA and proteins in fifty-two gliomas of different grades of malignancy. The UL83 viral region, the early beta 2.7 RNA and viral protein were detected in 73%, 36% and 57% by qPCR, ISH and IHC, respectively. Positivity of the viral targets and viral load was independent of tumor type or grade suggesting no correlation between viral presence and tumor progression. Our results demonstrate high prevalence of the virus in gliomas from Brazilian patients, contributing to a better understanding of the association between HCMV infection and gliomas worldwide and supporting further investigations of the virus oncomodulatory properties.

Indexed as

DNA, ViralGene ExpressionViral LoadBrazilCytomegalovirusCytomegalovirus InfectionsGliomaHumansImmunohistochemistryIn Situ HybridizationNeoplasm GradingRNA, ViralViral ProteinsDNA, ViralRNA, ViralViral Proteins

Identifiers

PMID27458810
PMCPMC4961403
OpenAlexW2486739353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.